Have one to sell? Sell yours here
Cancer Chemotherapy & Biological Response Modifiers Annual 15 (Cancer Chemotherapy and Biological Response Modifiers)
  
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Cancer Chemotherapy & Biological Response Modifiers Annual 15 (Cancer Chemotherapy and Biological Response Modifiers) [Hardcover]

D. L. Longo (Editor), H. M. Pinedo (Editor), Bruce A. Chabner (Editor)


Available from these sellers.


Textbook Student FREE Two-Day Shipping for Students. Learn more


Book Description

0444820566 978-0444820563 January 1994 1
"Cancer Chemotherapy and Biological Response Modifiers" is a successful annual book series of approximately 15 years standing. Continuing in the tradition of the series, Annual 15 offers critical reviews of the recent, major developments in pharmacology of anti-cancer agents, the area of biologicals and the clinical management of the cancer patient. In 1993, new compounds continued to generate great interest, both clinically and in the laboratory. The taxanes will clearly gain important roles in the treatment of a number of solid tumors, especially breast, lung, ovarian and head and neck cancer. Similarly, the camptothecins (esp. CPT-11, topotecan), are showing interesting activity in solid tumors. The uses and pharmacology of these as well as the other new agents reviewed in this year's annual will undoubtedly become the basis of a better cancer chemotherapy in the near future. Another approach which seems promising is the use of moderately high and particularly high dose chemotherapy in solid tumors. Unfortunately, many of the reported studies are not randomized. There is an urgent need to compare this approach with conventional chemotherapy as there are only very few clear cut indications for high dose chemotherapy. Studies which seem most relevant are upfront high dose chemotherapy compared to conventional chemotherapy in high risk testicular non-seminomas. Also, results of the Dutch and Italian randomized adjuvant chemotherapy trials in breast cancer are being awaited with great interest. Biological treatment continues to yield interesting results. Early clinical trials in the field of anti-angiogenesis, anti-invasive and anti-metastatic drugs have been initiated. New cytokines are being developed and entering the clinic as well. Altogether, medical oncology in the 1990s is developing into a most complex discipline. The reader will find each of the developments summarized by front runners in the field.

Product Details

  • Hardcover: 715 pages
  • Publisher: Elsevier Science Pub Co; 1 edition (January 1994)
  • Language: English
  • ISBN-10: 0444820566
  • ISBN-13: 978-0444820563
  • Product Dimensions: 10.8 x 8 x 2 inches
  • Shipping Weight: 4.1 pounds

Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject